新龍國際(00529.HK)附屬出售新龍泰國股份套現近9千萬元
新龍國際(00529.HK)公布,間接非全資附屬公司Thai Alliance Co., Ltd.上周五(25日)在泰國證交所出售合共1,000萬股新龍泰國股份,佔其新龍泰國已發行股份2.86%,出售總代價為3.6億元泰銖、折合約8,988.3萬港元。
於出售事項後,公司及其附屬公司合共持有2.145億股新龍泰國股份,佔新龍泰國實際權益之約60.77%。集團預期因出售事項而確認未經審核稅前收益約6,500萬元。
由於新龍泰國股份價格已大幅增長,集團欲把握機會,透過出售部份投資以變現部份收益,並增強集團的營運資金。集團擬將出售事項所得款項用於償還Thai Alliance Co., Ltd.的債務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.